These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 18501995)
21. 'Click peptide': a novel 'O-acyl isopeptide method' for peptide synthesis and chemical biology-oriented synthesis of amyloid beta peptide analogues. Sohma Y; Taniguchi A; Yoshiya T; Chiyomori Y; Fukao F; Nakamura S; Skwarczynski M; Okada T; Ikeda K; Hayashi Y; Kimura T; Hirota S; Matsuzaki K; Kiso Y J Pept Sci; 2006 Dec; 12(12):823-8. PubMed ID: 17131295 [TBL] [Abstract][Full Text] [Related]
22. Aggregation of Abeta(1-42) in the presence of short peptides: conformational studies. Laczkó I; Vass E; Soós K; Fülöp L; Zarándi M; Penke B J Pept Sci; 2008 Jun; 14(6):731-41. PubMed ID: 18247430 [TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of indane-2-arylhydrazinylmethylene-1,3-diones and indol-2-aryldiazenylmethylene-3-ones as beta-amyloid aggregation inhibitors. Catto M; Aliano R; Carotti A; Cellamare S; Palluotto F; Purgatorio R; De Stradis A; Campagna F Eur J Med Chem; 2010 Apr; 45(4):1359-66. PubMed ID: 20137834 [TBL] [Abstract][Full Text] [Related]
24. Anti-amyloid activity of the C-terminal domain of proSP-C against amyloid beta-peptide and medin. Nerelius C; Gustafsson M; Nordling K; Larsson A; Johansson J Biochemistry; 2009 May; 48(17):3778-86. PubMed ID: 19281242 [TBL] [Abstract][Full Text] [Related]
26. Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptides. Rossi M; Piovesan P; Ghirardi O; Mastroianni D; Bombardi V; Battistini L; Cencioni MT; Capobianco D; Borsini F; Colombo M; Verdoliva A Mol Immunol; 2009 Aug; 46(13):2524-32. PubMed ID: 19535144 [TBL] [Abstract][Full Text] [Related]
27. Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide. Rocha S; Thünemann AF; Pereira Mdo C; Coelho M; Möhwald H; Brezesinski G Biophys Chem; 2008 Sep; 137(1):35-42. PubMed ID: 18625543 [TBL] [Abstract][Full Text] [Related]
28. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers. Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231 [TBL] [Abstract][Full Text] [Related]
29. Switch-peptides: design and characterization of controllable super-amyloid-forming host-guest peptides as tools for identifying anti-amyloid agents. Camus MS; Dos Santos S; Chandravarkar A; Mandal B; Schmid AW; Tuchscherer G; Mutter M; Lashuel HA Chembiochem; 2008 Sep; 9(13):2104-12. PubMed ID: 18683159 [TBL] [Abstract][Full Text] [Related]
30. Inhibitors of protein aggregation and toxicity. Amijee H; Madine J; Middleton DA; Doig AJ Biochem Soc Trans; 2009 Aug; 37(Pt 4):692-6. PubMed ID: 19614577 [TBL] [Abstract][Full Text] [Related]
31. Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for Abeta fibril formation. Byeon SR; Lee JH; Sohn JH; Kim DC; Shin KJ; Yoo KH; Mook-Jung I; Lee WK; Kim DJ Bioorg Med Chem Lett; 2007 Mar; 17(5):1466-70. PubMed ID: 17270435 [TBL] [Abstract][Full Text] [Related]
32. RNA aptamers selected against amyloid beta-peptide (Abeta) inhibit the aggregation of Abeta. Takahashi T; Tada K; Mihara H Mol Biosyst; 2009 Sep; 5(9):986-91. PubMed ID: 19668864 [TBL] [Abstract][Full Text] [Related]
33. Transformation of the amyloidogenic peptide amylin(20-29) into its corresponding peptoid and retropeptoid: access to both an amyloid inhibitor and template for self-assembled supramolecular tapes. Elgersma RC; Mulder GE; Kruijtzer JA; Posthuma G; Rijkers DT; Liskamp RM Bioorg Med Chem Lett; 2007 Apr; 17(7):1837-42. PubMed ID: 17276062 [TBL] [Abstract][Full Text] [Related]
34. Restored degradation of the Alzheimer's amyloid-beta peptide by targeting amyloid formation. Crouch PJ; Tew DJ; Du T; Nguyen DN; Caragounis A; Filiz G; Blake RE; Trounce IA; Soon CP; Laughton K; Perez KA; Li QX; Cherny RA; Masters CL; Barnham KJ; White AR J Neurochem; 2009 Mar; 108(5):1198-207. PubMed ID: 19141082 [TBL] [Abstract][Full Text] [Related]
35. Conformational and thermal characterization of a synthetic peptidic fragment inspired from human tropoelastin: Signature of the amyloid fibers. Dandurand J; Samouillan V; Lacoste-Ferre MH; Lacabanne C; B Bochicchio ; Pepe A Pathol Biol (Paris); 2014 Apr; 62(2):100-7. PubMed ID: 24674658 [TBL] [Abstract][Full Text] [Related]
36. Backbone-modified amylin derivatives: implications for amyloid inhibitor design and as template for self-assembling bionanomaterials. Elgersma RC; Posthuma G; Rijkers DT; Liskamp RM J Pept Sci; 2007 Nov; 13(11):709-16. PubMed ID: 17890652 [TBL] [Abstract][Full Text] [Related]
37. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Song MS; Rauw G; Baker GB; Kar S Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381 [TBL] [Abstract][Full Text] [Related]
38. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight. Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107 [TBL] [Abstract][Full Text] [Related]
39. A molecular dynamics study of the interaction of D-peptide amyloid inhibitors with their target sequence reveals a potential inhibitory pharmacophore conformation. Esteras-Chopo A; Morra G; Moroni E; Serrano L; Lopez de la Paz M; Colombo G J Mol Biol; 2008 Oct; 383(1):266-80. PubMed ID: 18703072 [TBL] [Abstract][Full Text] [Related]